S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
Log in
NASDAQ:BDTX

Black Diamond Therapeutics News Headlines

$23.73
-1.91 (-7.45 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$23.27
Now: $23.73
$26.13
50-Day Range
$23.71
MA: $27.08
$29.76
52-Week Range
$17.63
Now: $23.73
$46.25
Volume371,250 shs
Average Volume486,956 shs
Market Capitalization$857.03 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Black Diamond Therapeutics (NASDAQ BDTX) News Headlines Today

Source:
SourceHeadline
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Insider Christopher D. Roberts Sells 2,500 SharesBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Insider Christopher D. Roberts Sells 2,500 Shares
americanbankingnews.com - March 4 at 9:26 PM
Black Diamond Therapeutics (NASDAQ:BDTX) Trading Up 6.5%Black Diamond Therapeutics (NASDAQ:BDTX) Trading Up 6.5%
americanbankingnews.com - February 17 at 7:26 PM
Insider Selling: Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Insider Sells 4,078 Shares of StockInsider Selling: Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Insider Sells 4,078 Shares of Stock
americanbankingnews.com - February 12 at 9:38 PM
Black Diamond Therapeutics to Present at the BMO Biopharma Spotlight SeriesBlack Diamond Therapeutics to Present at the BMO Biopharma Spotlight Series
feeds.benzinga.com - February 11 at 4:48 PM
We Think Black Diamond Therapeutics (NASDAQ:BDTX) Can Afford To Drive Business GrowthWe Think Black Diamond Therapeutics (NASDAQ:BDTX) Can Afford To Drive Business Growth
finance.yahoo.com - February 3 at 7:56 AM
2 Biotech Stocks That Could Double in 2021; Canaccord Says ‘Buy’2 Biotech Stocks That Could Double in 2021; Canaccord Says ‘Buy’
finance.yahoo.com - February 2 at 9:45 PM
Black Diamond Therapeutics Inc.Black Diamond Therapeutics Inc.
wsj.com - January 21 at 7:18 PM
Black Diamond Therapeutics Announces Appointment of Oncology Clinical Development Veteran Dr. Kapil Dhingra to Board of DirectorsBlack Diamond Therapeutics Announces Appointment of Oncology Clinical Development Veteran Dr. Kapil Dhingra to Board of Directors
finance.yahoo.com - January 20 at 9:30 AM
Black Diamond Therapeutics to Present at the J.P. Morgan 39th Annual Healthcare ConferenceBlack Diamond Therapeutics to Present at the J.P. Morgan 39th Annual Healthcare Conference
finance.yahoo.com - January 5 at 9:48 AM
Is BDTX A Good Stock To Buy Now?Is BDTX A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 2:43 PM
What Kind Of Shareholders Own Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)?What Kind Of Shareholders Own Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)?
finance.yahoo.com - December 5 at 9:06 AM
Black Diamond Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceBlack Diamond Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
finance.yahoo.com - November 24 at 9:38 AM
Black Diamond nominates development candidate for glioblastoma programBlack Diamond nominates development candidate for glioblastoma program
seekingalpha.com - November 20 at 1:45 PM
Black Diamond Therapeutics Provides Update on GBM Program and Presents Pre-Clinical Data at the 2020 SNO Annual MeetingBlack Diamond Therapeutics Provides Update on GBM Program and Presents Pre-Clinical Data at the 2020 SNO Annual Meeting
finance.yahoo.com - November 20 at 8:44 AM
Black Diamond Therapeutics to Present at the Jefferies 2020 Virtual London Healthcare ConferenceBlack Diamond Therapeutics to Present at the Jefferies 2020 Virtual London Healthcare Conference
finance.yahoo.com - November 11 at 8:04 AM
Black Diamond Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateBlack Diamond Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - November 10 at 10:34 AM
Edited Transcript of ABBV.N earnings conference call or presentation 30-Oct-20 1:00pm GMT - Yahoo FinanceEdited Transcript of ABBV.N earnings conference call or presentation 30-Oct-20 1:00pm GMT - Yahoo Finance
finance.yahoo.com - October 31 at 9:25 AM
AbbVie (ABBV) Q3 2020 Earnings Call Transcript - Motley FoolAbbVie (ABBV) Q3 2020 Earnings Call Transcript - Motley Fool
fool.com - October 31 at 9:25 AM
I-Mab Announces Upcoming Participation at November Conferences - PRNewswireI-Mab Announces Upcoming Participation at November Conferences - PRNewswire
prnewswire.com - October 28 at 12:29 PM
I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting - PRNewswireI-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting - PRNewswire
prnewswire.com - October 27 at 2:58 PM
Black Diamond Therapeutics Presents Pre-Clinical Data on Lead Product Candidate BDTX-189 at the 32nd EORTC-NCI-AACR Virtual SymposiumBlack Diamond Therapeutics Presents Pre-Clinical Data on Lead Product Candidate BDTX-189 at the 32nd EORTC-NCI-AACR Virtual Symposium
finance.yahoo.com - October 26 at 7:48 AM
I-Mab to Present Phase 1 Data of Lemzoparlimab at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting - PRNewswireI-Mab to Present Phase 1 Data of Lemzoparlimab at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting - PRNewswire
prnewswire.com - October 15 at 8:07 AM
Fosun unit to begin U.S. trial of COVID-19 antibody treatment soon - ReutersFosun unit to begin U.S. trial of COVID-19 antibody treatment soon - Reuters
reuters.com - October 8 at 10:32 PM
CBC-incubated Everest Medicines Successfully Lists on HKEX - PRNewswireCBC-incubated Everest Medicines Successfully Lists on HKEX - PRNewswire
prnewswire.com - October 8 at 10:32 PM
Ant Groups $35 bln IPO unlikely to be hurt by possible U.S. curbs, analysts say - NasdaqAnt Group's $35 bln IPO unlikely to be hurt by possible U.S. curbs, analysts say - Nasdaq
nasdaq.com - October 8 at 12:31 PM
EARNINGS-Dominos quarterly sales beat as pandemic boosts pizza demand - NasdaqEARNINGS-Domino's quarterly sales beat as pandemic boosts pizza demand - Nasdaq
nasdaq.com - October 8 at 12:31 PM
BioNTech expects pre-reserved vaccine bottling capacity to be freed up - NasdaqBioNTech expects pre-reserved vaccine bottling capacity to be freed up - Nasdaq
nasdaq.com - October 8 at 12:31 PM
UK regulator seeks to review O2-Virgin deal - NasdaqUK regulator seeks to review O2-Virgin deal - Nasdaq
nasdaq.com - October 8 at 12:31 PM
Fosun unit to begin U.S. trial of COVID-19 antibody treatment soon - Yahoo Eurosport UKFosun unit to begin U.S. trial of COVID-19 antibody treatment soon - Yahoo Eurosport UK
uk.finance.yahoo.com - October 8 at 12:31 PM
I-Mab Receives China CDE Approval to Initiate Phase 3 Clinical Trial of Eftansomatropin in Pediatric Patients with Growth Hormone Deficiency - PRNewswireI-Mab Receives China CDE Approval to Initiate Phase 3 Clinical Trial of Eftansomatropin in Pediatric Patients with Growth Hormone Deficiency - PRNewswire
prnewswire.com - September 30 at 8:20 AM
I-Mab Announces China NMPA Clearance for Phase 1 Clinical Trial of Lemzoparlimab in Relapsed or Refractory Advanced Lymphoma - PRNewswireI-Mab Announces China NMPA Clearance for Phase 1 Clinical Trial of Lemzoparlimab in Relapsed or Refractory Advanced Lymphoma - PRNewswire
prnewswire.com - September 21 at 9:06 AM
Analysts Are Betting On I-Mab (NASDAQ:IMAB) With A Big Upgrade This Week - Yahoo FinanceAnalysts Are Betting On I-Mab (NASDAQ:IMAB) With A Big Upgrade This Week - Yahoo Finance
finance.yahoo.com - September 20 at 1:00 PM
MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer - PRNewswireMorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer - PRNewswire
prnewswire.com - September 17 at 11:12 PM
Great Yield and Packed Pipeline Signal a Buy for AbbVie - NasdaqGreat Yield and Packed Pipeline Signal a Buy for AbbVie - Nasdaq
nasdaq.com - September 17 at 8:10 AM
CBC Continues Strong Momentum and Reaches Major Milestones Across Healthcare Investment Platforms - Yahoo FinanceCBC Continues Strong Momentum and Reaches Major Milestones Across Healthcare Investment Platforms - Yahoo Finance
finance.yahoo.com - September 15 at 1:10 AM
Jeff Bezos-backed cancer testing company Grail files for U.S. IPO - NasdaqJeff Bezos-backed cancer testing company Grail files for U.S. IPO - Nasdaq
nasdaq.com - September 9 at 12:34 PM
I-Mab (IMAB) Surges: Stock Moves 5.5% Higher - Yahoo FinanceI-Mab (IMAB) Surges: Stock Moves 5.5% Higher - Yahoo Finance
finance.yahoo.com - September 9 at 12:34 PM
Qiagen readies launch of rapid COVID-19 antigen test - NasdaqQiagen readies launch of rapid COVID-19 antigen test - Nasdaq
nasdaq.com - September 8 at 8:16 PM
AbbVie I-Mab Cancer Deal, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking AlphaAbbVie I-Mab Cancer Deal, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha
seekingalpha.com - September 8 at 8:10 AM
BUZZ-U.S. STOCKS ON THE MOVE-I-Mab, AnPac Bio-Medical Science, DPW Holdings - NasdaqBUZZ-U.S. STOCKS ON THE MOVE-I-Mab, AnPac Bio-Medical Science, DPW Holdings - Nasdaq
nasdaq.com - September 6 at 7:09 AM
AbbVie to develop and sell China-based I-Mabs cancer drug - NasdaqAbbVie to develop and sell China-based I-Mab's cancer drug - Nasdaq
nasdaq.com - September 5 at 12:52 PM
Nasdaq falls 3% as tech selloff resumes - NasdaqNasdaq falls 3% as tech selloff resumes - Nasdaq
nasdaq.com - September 4 at 3:41 PM
AbbVie to develop and sell China-based I-Mabs cancer drug - ReutersAbbVie to develop and sell China-based I-Mab's cancer drug - Reuters
reuters.com - September 4 at 3:41 PM
Pre-Open Stock Movers 9/04: (IMAB) (KCAC) (NX) (CVAC) (W) (OSKT) (DOCU) - StreetInsider.comPre-Open Stock Movers 9/04: (IMAB) (KCAC) (NX) (CVAC) (W) (OSKT) (DOCU) - StreetInsider.com
streetinsider.com - September 4 at 9:45 AM
BRIEF-I-Mab Says Abbvie Has A Right Of First Negotiation To In-License Further Development And Commercialization Of 2 Additional Lemzoparlimab-Based Bispecific Antibodies- Conf. Call - ReutersBRIEF-I-Mab Says Abbvie Has A Right Of First Negotiation To In-License Further Development And Commercialization Of 2 Additional Lemzoparlimab-Based Bispecific Antibodies- Conf. Call - Reuters
reuters.com - September 4 at 9:45 AM
I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium - PRNewswireI-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium - PRNewswire
prnewswire.com - September 4 at 9:45 AM
The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent - Yahoo FinanceThe Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent - Yahoo Finance
finance.yahoo.com - September 3 at 3:38 AM
IMAB (IMAB) Q2 2020 Earnings Call Transcript - Motley FoolIMAB (IMAB) Q2 2020 Earnings Call Transcript - Motley Fool
fool.com - September 1 at 6:41 PM
What Kind Of Investors Own Most Of I-Mab (NASDAQ:IMAB)? - Yahoo FinanceWhat Kind Of Investors Own Most Of I-Mab (NASDAQ:IMAB)? - Yahoo Finance
finance.yahoo.com - September 1 at 6:41 PM
The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent - BenzingaThe Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent - Benzinga
benzinga.com - September 1 at 8:40 AM
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.